Could FGF21 Be the Metabolic Holy Grail for Weight Loss and Longevity?
In this video, presenter Nick Norwitz explores recent research on the hormone fibroblast growth factor 21 (FGF21) and its potential to serve as a metabolic "holy grail" for weight loss and longevity. He outlines two key lines of evidence: (1) human studies where altering macronutrient intake dramatically raises circulating FGF21, which in turn boosts daily energy expenditure by roughly 600 kcal without additional exercise; and (2) animal experiments showing that increasing FGF21 signaling specifically in adipose tissue improves body composition and extends lifespan. Norwitz frames these findings as a possible breakthrough, questioning whether targeting FGF21 could allow people to eat more, stay leaner, and live longer, while acknowledging that further research is needed to translate these results into human therapies.
